We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 0.14% | 35.45 | 35.20 | 35.60 | 35.65 | 35.20 | 35.45 | 246,675 | 16:35:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.14 | 105.85M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/10/2022 13:49 | The ramper is also misrepresenting oral placebo studies with placebo Medical devices. It has been shown medical devices especially gels that are rubbed in have higher placebo effects then just taking an oral placebo. Recent research has shown that the placebo effect is not only similar for medical devices to medical trials; it is considerably larger, the effect of a sham device is almost three times that of an oral placebo. Placebo Treatment: Don't Eat It, Rub it! indications to suggest that a topical placebo induces stronger effects than an oral one. So Petrioc stop deflecting with just more and more misleading lies. Where is any adequately controlled study of MED3000 with a topical placebo. Or even with just a standard cooling lubricant/arousal gel? | lbo | |
25/10/2022 13:38 | When Futura describe the efficacy of MED3000, they are talking about improvement seen over the course of the treatment period (which was 1 month in the first trial, 3 months in the second), known as 'change vs. baseline'. Large improvements vs. baseline are common in the placebo groups in clinical trials of a wide range of conditions. There are many reasons why symptoms can improve over the course of a trial, of which the placebo effect is only one. To measure the actual effect of a placebo, we would need to compare the placebo to a control group who got no treatment at all. This hasn't been done for MED3000 | lbo | |
25/10/2022 13:31 | There's LiarBO doing what he does best - lying and stock bashing! According to him, FM57 was the 'worst' trial because participants believed they were using gel with GTN. If his theory was correct, FM57 would have achieved the highest results. This is what actually happened though: During FM57, over 60% of all patients experienced a meaningful difference in improvement of their erections using recognised assessment techniques. FM71 results were highly positive, meeting all primary and secondary endpoints; are in line with data generated in the previous Phase 3 clinical study (“FM57”) and are broadly comparable with results from a recent “real world”, home user study. Cooper undertook a consumer marketing home use test (HUT) in the UK, France, and the Netherlands. Men with self-diagnosed ED were supplied a four-pack sample of MED3000 with the appropriate packaging leaflet. The results were in line with those seen in the FM57 1,000 patient clinical trial, where over two-thirds of patients saw a clinically meaningful benefit. In other words, MED3000 was found to be efficacious in 60% of patients, in all three trials, whether they believed it contained a known vasodilator, GTN, or not. LiarBO has also previously claimed that placebo effect can affect 'up to 50% of patients', so if (big 'if'!) he's correct, when you see improvements of 60% in three separate trials, you can bet your bottom dollar there's more than placebo effect going on here. He will of course try to rubbish these trials, saying they weren't placebo controlled, double blind blah blah blah, because he's such an expert in the field. Really he's just a charlatan trying to stop ordinary people making a few quid by investing here. He's nothing but a disgruntled ex-investor, crying into his beer. Don't take my word for it though, after all I'm a just a 'proven liar with multi IDs ramping all over the internet' lol! DYOR. | petroc | |
24/10/2022 08:31 | Also it was NOT ˜merely rubbing’ in a gel that caused the ‘trick’ In FM57, FM71 and the consumer HUT. It was because all the studies were inadequately controlled. There was the belief by the participants that they rubbing a gel ‘proven’ to treat Erectile Dysfunction. And worse in FM57! The participants believed they were rubbing in Med2005 a Viagra type gel with GTN a known vasodilator. Therein was what caused the placebo effects of ˜merely rubbing’ the placebo Med3000 gel in FM57 ‘You are the active ingredient’ There is no evidence for the evaporative mode of action from the clinical trials. To show that the evaporation is what makes MED3000 work, you'd need to compare it to a non-evaporative gel. Trinity Research even openly admitted the hypothesised effects ‘believed&rsqu Trinity research: Presumably the effect is comparable to the cold-induced vasodilation (CIVD) that occurs with extremities such as toes and fingers. Despite being a well-known effect, the mechanisms of CIVD are still disputed, but the pathways involved could well be similar. Interestingly, the precise mechanism of action does not need to be elucidated for the regulators to be comfortable for a product to be approved as medical device | lbo | |
22/10/2022 15:41 | And yet still you have repeatedly failed to provide any non deficient evidence from an adequately controlled and blinded studies to support your false claims with zero disclaimers on ADVFN that its ‘FACTS’ ‘it works? Seems it is you who is suffering trom a serious case of ad-hominem fallacy! LOL 15 Ways to Spot Stock Discussion Board Rampers 3. They attack those who disagree with their lofty predictions. They cannot back up their arguments with a rational discussion, so they resort to petty name calling and telling others who disagree with them that they are "full of it." 4. You cannot have an intelligent discussion with these types. They will do whatever they can to discredit those who disagree with them by spreading false information. | lbo | |
22/10/2022 13:04 | When you do a bit of research about people who endlessly repeat things, you find some interesting stuff. I think I may have discovered why the stock basher does what he does. 'A person who has had a traumatic experience in the past may keep acting out these traumas in their dreams. Only by talking about the trauma repeatedly, trying to make sense of it, can they hope to end these dreams.' That sounds amazingly like someone who ignored all the common sense guidelines about investing and put all their money on something that failed, CSD500 for example, and then lost everything. Another symptom is to call everyone else a liar if they challenge them. hxxps://www.psychmec | petroc | |
21/10/2022 18:05 | Heh heh heh! | petroc | |
21/10/2022 17:40 | Again yet another false post by Petroc. You claimed ‘it works’ and ‘FACTS’. As per the FTC, ASA and court rulings. There is no evidence that is not ‘deficient&rsq petroc - 09 Jan 2022 - 16:44:16 - 10345 of 10423 Of course it works petroc22 Jan '22 - 19:08 - 10569 of 10768 What is not to love Eroxon /MED3000 - HERE ARE THE FACTS And the reason the proof of any effect beyond a placebo doesn’t exist. Is because the study has not been carried out. Or if it has. The results have never been released. It could be because that study would also prove Med3000 has no effect beyond a placebo. So you have again deliberately made another false statement with no disclaimers on ADVFN stating ‘in fact all the evidence suggests that it works in 60% of patients. As you know all that so called evidence is from inadequately controlled studies and is ˜deficient&rsq As per the ADVFN T&Cs 9. ACCURACY OF INFORMATION ˜You bear all risks from any uses or results of using any Information. You are responsible for validating the integrity of any Information received over the Internet’ | lbo | |
21/10/2022 17:12 | Yep, definitely 'a compulsive repetition of utterances'. There's no doubt about it, LiarBO is clinically insane. | petroc | |
21/10/2022 14:39 | It was NOT ‘merely rubbing’ in a gel. In FM57 and FM71 which were inadequately controlled. There was the belief by the participants that they rubbing a gel ‘proven’ to treat Erectile Dysfunction. And worse in FM57! The participants believed they were rubbing in a ‘Viagra type’ gel with GTN a known vasodilator. Therein was the placebo effects beyond ‘merely rubbing’ of the placebo Med3000 gel in FM57 ‘You are the active ingredient’ There is no evidence for the evaporative mode of action from the clinical trials. To show that the evaporation is what makes MED3000 work, you'd need to compare it to a non-evaporative gel. Trinity Research even openly admitted the hypothesised effects ‘believed&rsqu Trinity research: Presumably the effect is comparable to the cold-induced vasodilation (CIVD) that occurs with extremities such as toes and fingers. Despite being a well-known effect, the mechanisms of CIVD are still disputed, but the pathways involved could well be similar. Interestingly, the precise mechanism of action does not need to be elucidated for the regulators to be comfortable for a product to be approved as medical device | lbo | |
21/10/2022 12:10 | Palilalia, a disorder of speech characterized by compulsive repetitions of utterances has been found in various neurological and psychiatric disorders. It has commonly been interpreted as a defect of motor speech. | petroc | |
21/10/2022 11:54 | If rubbing Med3000 works for a man then rubbing any cooling lubricant/arousal gel will also work. Med3000 has no proven effects beyond any placebo in any adequately controlled study. So rubbing any cooling placebo gel including an arousal gel would have the same effects ‘You are the active ingredient’ | lbo | |
21/10/2022 11:49 | Don't Eat It, Rub it! I agree don't eat little blue pills with all their side effects, get some Med and smear, not rub, it on - and off you go to stiffy-land - without the multitude of risks !! - heaven in a tube | mikethebike4 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions